395 related articles for article (PubMed ID: 10551777)
21. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
22. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
[TBL] [Abstract][Full Text] [Related]
23. Termination of growth hormone pulse-induced STAT5b signaling.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
[TBL] [Abstract][Full Text] [Related]
24. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
Rui L; Carter-Su C
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7172-7. PubMed ID: 10377387
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
[TBL] [Abstract][Full Text] [Related]
27. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
28. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling.
Gu F; Dubé N; Kim JW; Cheng A; Ibarra-Sanchez Mde J; Tremblay ML; Boisclair YR
Mol Cell Biol; 2003 Jun; 23(11):3753-62. PubMed ID: 12748279
[TBL] [Abstract][Full Text] [Related]
29. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction.
Favre H; Benhamou A; Finidori J; Kelly PA; Edery M
FEBS Lett; 1999 Jun; 453(1-2):63-6. PubMed ID: 10403376
[TBL] [Abstract][Full Text] [Related]
30. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
Stofega MR; Herrington J; Billestrup N; Carter-Su C
Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
[TBL] [Abstract][Full Text] [Related]
31. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
[TBL] [Abstract][Full Text] [Related]
32. Increased SH2-Bbeta content and membrane association in transgenic mice overexpressing GH.
Miquet JG; Sotelo AI; Bartke A; Turyn D
J Endocrinol; 2005 May; 185(2):301-6. PubMed ID: 15845922
[TBL] [Abstract][Full Text] [Related]
33. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
34. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins.
Hackett RH; Wang YD; Sweitzer S; Feldman G; Wood WI; Larner AC
J Biol Chem; 1997 Apr; 272(17):11128-32. PubMed ID: 9111009
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
[TBL] [Abstract][Full Text] [Related]
36. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
37. The role of signal transducer and activator of transcription 5 in the inhibitory effects of GH on adipocyte differentiation.
Richter HE; Albrektsen T; Billestrup N
J Mol Endocrinol; 2003 Apr; 30(2):139-50. PubMed ID: 12683938
[TBL] [Abstract][Full Text] [Related]
38. The role of GH receptor tyrosine phosphorylation in Stat5 activation.
Hansen JA; Hansen LH; Wang X; Kopchick JJ; Gouilleux F; Groner B; Nielsen JH; Møldrup A; Galsgaard ED; Billestrup N
J Mol Endocrinol; 1997 Jun; 18(3):213-21. PubMed ID: 9195475
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
40. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
